COVID-19: Epidemiological Update for the Hauts-de-France Region as of September 16, 2021

Key Points

  • Continued decline in virological indicators (incidence and positivity rates) in Week 36 across most regions of Hauts-de-France, with viral circulation remaining higher among those aged 20–39;

  • Gradual easing of pressure on healthcare services, notably with a decrease in new hospitalizations and new admissions to critical care units again observed in week 36;

  • As of September 14, nearly 4 out of 5 residents of Hauts-de-France (73.6%) had received at least one dose of the COVID-19 vaccine, and more than two-thirds (69.8%) had completed their vaccination series, though subregional disparities persist.

In relation to

Our latest news

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?

news

Call for Nominations for the Renewal of the Scientific Advisory Board of the...

news

Growing Up with Screens. A special report in *La Santé en action* No. 474,...